Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.24
WMGI's Cash to Debt is ranked lower than
88% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 2.59 vs. WMGI: 0.24 )
Ranked among companies with meaningful Cash to Debt only.
WMGI' s Cash to Debt Range Over the Past 10 Years
Min: 0.18  Med: 0.30 Max: 1.37
Current: 0.24
0.18
1.37
Equity to Asset 0.51
WMGI's Equity to Asset is ranked lower than
70% of the 301 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. WMGI: 0.51 )
Ranked among companies with meaningful Equity to Asset only.
WMGI' s Equity to Asset Range Over the Past 10 Years
Min: 0.31  Med: 0.53 Max: 0.79
Current: 0.51
0.31
0.79
F-Score: 4
Z-Score: 0.64
M-Score: -1.41
WACC vs ROIC
5.05%
-28.05%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -45.72
WMGI's Operating margin (%) is ranked lower than
71% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 1.90 vs. WMGI: -45.72 )
Ranked among companies with meaningful Operating margin (%) only.
WMGI' s Operating margin (%) Range Over the Past 10 Years
Min: -116.46  Med: -14.25 Max: -2.74
Current: -45.72
-116.46
-2.74
Net-margin (%) -71.90
WMGI's Net-margin (%) is ranked lower than
72% of the 309 Companies
in the Global Medical Devices industry.

( Industry Median: 0.86 vs. WMGI: -71.90 )
Ranked among companies with meaningful Net-margin (%) only.
WMGI' s Net-margin (%) Range Over the Past 10 Years
Min: -113.05  Med: -22.86 Max: -7.84
Current: -71.9
-113.05
-7.84
ROE (%) -55.90
WMGI's ROE (%) is ranked lower than
80% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 1.52 vs. WMGI: -55.90 )
Ranked among companies with meaningful ROE (%) only.
WMGI' s ROE (%) Range Over the Past 10 Years
Min: -64.55  Med: -24.23 Max: -5.19
Current: -55.9
-64.55
-5.19
ROA (%) -30.55
WMGI's ROA (%) is ranked lower than
73% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: -0.71 vs. WMGI: -30.55 )
Ranked among companies with meaningful ROA (%) only.
WMGI' s ROA (%) Range Over the Past 10 Years
Min: -40.3  Med: -10.97 Max: -3.73
Current: -30.55
-40.3
-3.73
ROC (Joel Greenblatt) (%) -79.38
WMGI's ROC (Joel Greenblatt) (%) is ranked lower than
66% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 3.61 vs. WMGI: -79.38 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
WMGI' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -197.56  Med: -39.00 Max: -18
Current: -79.38
-197.56
-18
Revenue Growth (3Y)(%) -2.50
WMGI's Revenue Growth (3Y)(%) is ranked lower than
70% of the 229 Companies
in the Global Medical Devices industry.

( Industry Median: 3.60 vs. WMGI: -2.50 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
WMGI' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -14.9  Med: -5.30 Max: -2.5
Current: -2.5
-14.9
-2.5
EPS Growth (3Y)(%) 89.20
WMGI's EPS Growth (3Y)(%) is ranked higher than
93% of the 198 Companies
in the Global Medical Devices industry.

( Industry Median: 2.60 vs. WMGI: 89.20 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
WMGI' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -38.1  Med: 60.00 Max: 89.2
Current: 89.2
-38.1
89.2
» WMGI's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-05-05)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2015

WMGI Guru Trades in Q2 2015

Columbia Wanger 2,524,644 sh (+9.79%)
Ken Fisher 2,367,484 sh (+2.19%)
Mario Gabelli 211,000 sh (unchged)
Jim Simons Sold Out
Steven Cohen Sold Out
John Keeley 1,769,391 sh (-4.26%)
Paul Tudor Jones 75,000 sh (-25.00%)
» More
Q3 2015

WMGI Guru Trades in Q3 2015

Jim Simons 337,827 sh (New)
John Keeley 1,921,796 sh (+8.61%)
Mario Gabelli 211,000 sh (unchged)
Paul Tudor Jones Sold Out
Columbia Wanger 2,486,149 sh (-1.52%)
Ken Fisher 2,283,400 sh (-3.55%)
» More
Q4 2015

WMGI Guru Trades in Q4 2015

Steven Cohen 1,272,900 sh (New)
Columbia Wanger 2,679,268 sh (+7.77%)
Ken Fisher 2,358,437 sh (+3.29%)
Samuel Isaly 1,855,647 sh (unchged)
Mario Gabelli Sold Out
John Keeley 1,813,432 sh (-5.64%)
Jim Simons 214,011 sh (-36.65%)
» More
Q1 2016

WMGI Guru Trades in Q1 2016

Samuel Isaly 1,855,647 sh (unchged)
Ken Fisher 2,329,797 sh (-1.21%)
» More
» Details

Insider Trades

Latest Guru Trades with WMGI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Guru Investment Theses on Wright Medical Group NV

John Keeley Comments on Wright Medical Group - Apr 26, 2016

Health Care proved to be challenging this quarter and our leading detractors all came from this sector. Despite a positive quarter and the completion of a recent European based acquisition, Wright Medical Group (NASDAQ:WMGI) stock was pressured on fears of potential litigation involving metal to metal hip implants, which could exceed the company’s liability insurance. Other orthopedic companies have suffered from similar legal disputes involving alleged, early device failure in recent years. A judgement was recently handed down on its first case with 80% less in damages awarded than had been initially estimated. Regardless of what appears to be a favorable outcome, WMGI plans to appeal the case and ultimately hopes to certify and settle the class of claims well within its liability insurance limits. We believe WMGI will ultimately prevail on this issue and the stock remains attractive.



From Keeley All Cap Value Fund first quarter 2016 commentary.



Check out John Keeley latest stock trades

Top Ranked Articles about Wright Medical Group NV

John Keeley Comments on Wright Medical Group Guru stock highlight
Health Care proved to be challenging this quarter and our leading detractors all came from this sector. Despite a positive quarter and the completion of a recent European based acquisition, Wright Medical Group (NASDAQ:WMGI) stock was pressured on fears of potential litigation involving metal to metal hip implants, which could exceed the company’s liability insurance. Other orthopedic companies have suffered from similar legal disputes involving alleged, early device failure in recent years. A judgement was recently handed down on its first case with 80% less in damages awarded than had been initially estimated. Regardless of what appears to be a favorable outcome, WMGI plans to appeal the case and ultimately hopes to certify and settle the class of claims well within its liability insurance limits. We believe WMGI will ultimately prevail on this issue and the stock remains attractive. Read more...

Ratios

vs
industry
vs
history
P/B 1.84
WMGI's P/B is ranked higher than
70% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 2.93 vs. WMGI: 1.84 )
Ranked among companies with meaningful P/B only.
WMGI' s P/B Range Over the Past 10 Years
Min: 1.47  Med: 1.99 Max: 4.84
Current: 1.84
1.47
4.84
P/S 2.40
WMGI's P/S is ranked higher than
56% of the 291 Companies
in the Global Medical Devices industry.

( Industry Median: 3.18 vs. WMGI: 2.40 )
Ranked among companies with meaningful P/S only.
WMGI' s P/S Range Over the Past 10 Years
Min: 2.05  Med: 3.15 Max: 5.08
Current: 2.4
2.05
5.08
Current Ratio 2.71
WMGI's Current Ratio is ranked lower than
51% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 2.86 vs. WMGI: 2.71 )
Ranked among companies with meaningful Current Ratio only.
WMGI' s Current Ratio Range Over the Past 10 Years
Min: 1.87  Med: 2.54 Max: 3.25
Current: 2.71
1.87
3.25
Quick Ratio 1.60
WMGI's Quick Ratio is ranked lower than
62% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 2.09 vs. WMGI: 1.60 )
Ranked among companies with meaningful Quick Ratio only.
WMGI' s Quick Ratio Range Over the Past 10 Years
Min: 1.09  Med: 1.71 Max: 1.86
Current: 1.6
1.09
1.86
Days Inventory 348.84
WMGI's Days Inventory is ranked lower than
87% of the 286 Companies
in the Global Medical Devices industry.

( Industry Median: 136.13 vs. WMGI: 348.84 )
Ranked among companies with meaningful Days Inventory only.
WMGI' s Days Inventory Range Over the Past 10 Years
Min: 371.11  Med: 428.02 Max: 530.83
Current: 348.84
371.11
530.83
Days Sales Outstanding 115.13
WMGI's Days Sales Outstanding is ranked lower than
77% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 70.17 vs. WMGI: 115.13 )
Ranked among companies with meaningful Days Sales Outstanding only.
WMGI' s Days Sales Outstanding Range Over the Past 10 Years
Min: 64.15  Med: 72.28 Max: 115.13
Current: 115.13
64.15
115.13
Days Payable 94.59
WMGI's Days Payable is ranked higher than
67% of the 266 Companies
in the Global Medical Devices industry.

( Industry Median: 62.81 vs. WMGI: 94.59 )
Ranked among companies with meaningful Days Payable only.
WMGI' s Days Payable Range Over the Past 10 Years
Min: 51.36  Med: 84.70 Max: 156.08
Current: 94.59
51.36
156.08

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 58.69
WMGI's Price/Projected FCF is ranked lower than
98% of the 118 Companies
in the Global Medical Devices industry.

( Industry Median: 2.08 vs. WMGI: 58.69 )
Ranked among companies with meaningful Price/Projected FCF only.
WMGI' s Price/Projected FCF Range Over the Past 10 Years
Min: 75.56  Med: 75.56 Max: 75.56
Current: 58.69
Price/Median PS Value 0.78
WMGI's Price/Median PS Value is ranked higher than
74% of the 246 Companies
in the Global Medical Devices industry.

( Industry Median: 1.04 vs. WMGI: 0.78 )
Ranked among companies with meaningful Price/Median PS Value only.
WMGI' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.76  Med: 1.00 Max: 1.33
Current: 0.78
0.76
1.33
Price/Graham Number 2.65
WMGI's Price/Graham Number is ranked lower than
53% of the 178 Companies
in the Global Medical Devices industry.

( Industry Median: 2.14 vs. WMGI: 2.65 )
Ranked among companies with meaningful Price/Graham Number only.
WMGI' s Price/Graham Number Range Over the Past 10 Years
Min: 3.05  Med: 3.05 Max: 3.05
Current: 2.65
Earnings Yield (Greenblatt) (%) -8.01
WMGI's Earnings Yield (Greenblatt) (%) is ranked lower than
69% of the 310 Companies
in the Global Medical Devices industry.

( Industry Median: 0.50 vs. WMGI: -8.01 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
WMGI' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -9.48  Med: 3.10 Max: 8.9
Current: -8.01
-9.48
8.9

More Statistics

Revenue(Mil) $415
EPS $ -2.95
Beta0.57
Short Percentage of Float10.00%
52-Week Range $15.02 - 27.06
Shares Outstanding(Mil)102.71

Analyst Estimate

Dec16 Dec17 Dec18
Revenue(Mil) 703 786 911
EPS($) -0.78 -0.41 0.33
EPS without NRI($) -0.78 -0.41 0.33

Business Description

Industry: Medical Devices » Medical Devices
Compare:OCSE:WDH, ASX:COH, SZSE:300003, NAS:ABMD, NZSE:FPH, OCSE:GN » details
Traded in other countries:T98.Germany,
Tornier NV is a medical device company founded in the year 1940. The Company, along with its subsidiaries, provides solutions to surgeons that treat musculoskeletal injuries and disorders of the shoulder, elbow, wrist, hand, ankle and foot, which refers to as "extremity joints." It sells to these surgeons a joint replacement, trauma, sports medicine and biologic products to treat extremity joints. In foreign markets, the Company also offers joint replacement products for the hip and knee. Its customers are surgeon specialists focused on extremity injuries and disorders, along with general surgeons and podiatrists that perform extremities-related surgical procedures. The Company competes with orthopaedic manufacturers, such as DePuy Orthopaedics, Inc., a Johnson & Johnson subsidiary, Biomet, Inc., Zimmer Corporation and Stryker Corporation, and established mid-sized orthopaedic manufacturers, such as Arthrex, Inc., Wright Medical Group, Inc., Exactech, Inc., Integra LifeSciences Corporation and ArthroCare Corporation. The Company is subject to regulation by the U.S. Food and Drug Administration, other federal governmental agencies and state agencies in the United States and similar foreign governmental authorities in countries located outside the United States.
» More Articles for WMGI

Headlines

Articles On GuruFocus.com
John Keeley Comments on Wright Medical Group Apr 26 2016 

More From Other Websites
Wright Medical (WMGI) Shares March Higher, Can It Continue? Apr 20 2016
IHI Remained Flat, Hovering Around Its 52-Week High Apr 15 2016
Wright Medical Group N.V. to Host First Quarter 2016 Earnings Conference Call Apr 13 2016
Wright Medical Group N.V. to Host First Quarter 2016 Earnings Conference Call Apr 13 2016
WRIGHT MEDICAL GROUP N.V. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Apr 07 2016
WRIGHT MEDICAL GROUP N.V. Files SEC form 8-K, Change in Directors or Principal Officers Apr 06 2016
Wright Medical Group NV breached its 50 day moving average in a Bullish Manner : WMGI-US : April 5,... Apr 05 2016
ETF’s with exposure to Wright Medical Group NV : March 29, 2016 Mar 29 2016
ETF’s with exposure to Wright Medical Group NV : March 18, 2016 Mar 18 2016
Wright Medical Group NV :WMGI-US: Earnings Analysis: Q4, 2015 By the Numbers Mar 07 2016
Wright Medical Group N.V. Highlights Recent Innovations at the American Academy of Orthopaedic... Mar 02 2016
WRIGHT MEDICAL GROUP N.V. Financials Feb 27 2016
Wright Medical Q4 Loss Narrower than Expected, Sales Top Feb 25 2016
Why Wright Medical (WMGI) Stock is Up Today Feb 24 2016
Sales rocket for biotech manufacturer Feb 24 2016
Edited Transcript of WMGI earnings conference call or presentation 23-Feb-16 9:30pm GMT Feb 24 2016
Wright Medical reports 4Q loss Feb 23 2016
Wright Medical reports 4Q loss Feb 23 2016
WRIGHT MEDICAL GROUP N.V. Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 23 2016
Wright Medical Group N.V. Reports 2015 Fourth Quarter and Full-Year Financial Results and Provides... Feb 23 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK